Special Report
Published in:
Volume 6 / Year 2017 / Issue 2
Volume 6 / Year 2017 / Issue 2
Interchangeability of biosimilars in the US and around the world
Author(s): GaBI Journal Editor
Page: 97-8
Page: 97-8
Abstract: In this paper, differences across the world are highlighted when it comes to the interchangeability of biosimilars. The lack of harmonization makes it difficult for biosimilars makers and could… Read More »
Overview of the patent expiry of (non-)tyrosine kinase inhibitors approved for clinical use in the EU and the US
Author(s): Associate Professor Martine Lamfers, PhD, Professor Arnold G Vulto, PharmD, PhD, FCP, Professor Sieger Leenstra, MD, PhD, Subramanian Venkatesan, MSc
Page: 89-96
Page: 89-96
Author byline as per print journal: Subramanian Venkatesan, MSc; Associate Professor Martine Lamfers, PhD; Professor Sieger Leenstra, MD, PhD; Professor Arnold G Vulto, PharmD, PhD, FCP Abstract: Kinase inhibitors form the… Read More »